- Home
- Publications
- Publication Search
- Publication Details
Title
Range of adiposity and cardiorenal syndrome
Authors
Keywords
-
Journal
World Journal of Diabetes
Volume 11, Issue 8, Pages 322-350
Publisher
Baishideng Publishing Group Inc.
Online
2020-08-13
DOI
10.4239/wjd.v11.i8.322
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SGLT2 Inhibitors Produce Cardiorenal Benefits by Promoting Adaptive Cellular Reprogramming to Induce a State of Fasting Mimicry: A Paradigm Shift in Understanding Their Mechanism of Action
- (2020) Milton Packer DIABETES CARE
- Metabolically Healthy Obesity
- (2020) Matthias Blüher ENDOCRINE REVIEWS
- Impact of Transition in Metabolic Health and Obesity on the Incident Chronic Kidney Disease: A Nationwide Cohort Study
- (2020) Yun Kyung Cho et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction
- (2020) Jordana B. Cohen et al. JACC-Heart Failure
- Effect of mineralocorticoid receptor antagonists on cardiac function in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials
- (2019) Chris J. Kapelios et al. HEART FAILURE REVIEWS
- Obesity and heart failure with preserved ejection fraction: a paradox or something else?
- (2019) Marijana Tadic et al. HEART FAILURE REVIEWS
- GDF15 reflects beta cell function in obese patients independently of the grade of impairment of glucose metabolism
- (2019) M.H. Schernthaner-Reiter et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium
- (2019) Alex R Chang et al. BMJ-British Medical Journal
- Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease
- (2019) Iris E. Beldhuis et al. JACC-Heart Failure
- Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Co-Transporter 2 Inhibitors for Prevention of MajorAdverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Cardiovascular Outcomes Trials
- (2019) Thomas A. Zelniker et al. CIRCULATION
- Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: The ELSA-Brasil
- (2019) Paulo H. Harada et al. ATHEROSCLEROSIS
- Obesity, kidney dysfunction and hypertension: mechanistic links
- (2019) John E. Hall et al. Nature Reviews Nephrology
- Five-Year Outcomes of Gastric Bypass in Adolescents as Compared with Adults
- (2019) Thomas H. Inge et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Variability in Body Mass Index and Metabolic Health With Cardiometabolic Disease Risk
- (2019) Todd R. Sponholtz et al. Journal of the American Heart Association
- Risk Factors for Atrial Fibrillation in People With Type 1 Diabetes: An Observational Cohort Study of 36,258 Patients From the Swedish National Diabetes Registry
- (2019) Sara Hallström et al. DIABETES CARE
- Changes in Left Ventricular Mass and Geometry in the Older Adults: Role of Body Mass and Central Obesity
- (2019) Tetz C. Lee et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2019) Mansoor Husain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Complex interaction of obesity, intentional weight loss and heart failure: a systematic review and meta-analysis
- (2019) Rajiv Mahajan et al. HEART
- Natriuretic Peptides in the Cardiovascular System: Multifaceted Roles in Physiology, Pathology and Therapeutics
- (2019) Speranza Rubattu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
- (2019) Rajiv Agarwal et al. LANCET
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
- (2019) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Sacubitril-Valsartan, versus Valsartan, in Women Compared to Men with Heart Failure and Preserved Ejection Fraction: Insights from PARAGON-HF
- (2019) John J. V. McMurray et al. CIRCULATION
- Efficacy and safety of mineralocorticoid receptor antagonists with ACEI/ARB treatment for diabetic nephropathy: A meta‐analysis
- (2019) Chao Zuo et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Adverse Renal Response to Decongestion in the Obese Phenotype of Heart Failure With Preserved Ejection Fraction
- (2019) Yogesh N.V. Reddy et al. JOURNAL OF CARDIAC FAILURE
- Optimizing The Management of Obese HFpEF Phenotype: Can We Mind Both The Heart and The Kidney?
- (2019) Bharathi Upadhya et al. JOURNAL OF CARDIAC FAILURE
- The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
- (2019) Erik J.M. van Bommel et al. KIDNEY INTERNATIONAL
- Cardiometabolic risk factors and Framingham Risk Score in severely obese patients: Baseline data from DieTBra trial
- (2019) Annelisa S.A.C. Santos et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2019) Søren L Kristensen et al. Lancet Diabetes & Endocrinology
- Differential Regulation of ANP and BNP in Acute Decompensated Heart Failure: Deficiency of ANP
- (2019) Shawn H. Reginauld et al. JACC-Heart Failure
- Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial
- (2019) Hiddo J L Heerspink et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The Cardiorenal Syndrome in Heart Failure
- (2019) Maria Rosa Costanzo Heart Failure Clinics
- Leptin, cardiovascular diseases and type 2 diabetes mellitus
- (2018) Niki Katsiki et al. ACTA PHARMACOLOGICA SINICA
- Visceral and Intrahepatic Fat Are Associated with Cardiometabolic Risk Factors Above Other Ectopic Fat Depots: The Framingham Heart Study
- (2018) Jane J. Lee et al. AMERICAN JOURNAL OF MEDICINE
- Cellular mechanisms underlying obesity-induced arterial stiffness
- (2018) Annayya R. Aroor et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Cardiovascular and Metabolic Heterogeneity of Obesity
- (2018) Ian J. Neeland et al. CIRCULATION
- Obesity Paradox in Advanced Kidney Disease: From Bedside to the Bench
- (2018) Neda Naderi et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Serum adiponectin levels predict acute coronary syndrome (ACS) in patients with severe carotid stenosis
- (2018) Luca Liberale et al. VASCULAR PHARMACOLOGY
- The pharmacological management of metabolic syndrome
- (2018) Julie Rask Larsen et al. Expert Review of Clinical Pharmacology
- Elevated GlycA in severe obesity is normalized by bariatric surgery
- (2018) Arun Manmadhan et al. DIABETES OBESITY & METABOLISM
- Circulating leptin levels predict the decline in renal function with age in a sample of adult men (The Olivetti Heart Study)
- (2018) Lanfranco D’Elia et al. Internal and Emergency Medicine
- 24-Hour ambulatory blood pressure levels and control in a large cohort of adult outpatients with different classes of obesity
- (2018) Ilaria Figliuzzi et al. JOURNAL OF HUMAN HYPERTENSION
- Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories
- (2018) Kyle J Foreman et al. LANCET
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- (2018) Adrian F Hernandez et al. LANCET
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renal Resistive Index Predicts Post–Bariatric Surgery Renal Outcome in Nondiabetic Individuals with Severe Obesity
- (2018) Anna Solini et al. Obesity
- Body Mass Index, Natriuretic Peptides, and Risk of Adverse Outcomes in Patients With Heart Failure and Preserved Ejection Fraction: Analysis From the TOPCAT Trial
- (2018) Ambarish Pandey et al. Journal of the American Heart Association
- Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis
- (2017) Camille Lassale et al. EUROPEAN HEART JOURNAL
- The effects of short-term omission of daily medication on the pathophysiology of heart failure
- (2017) Silviu Dovancescu et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS-HF trial
- (2017) Arnaud Olivier et al. EUROPEAN JOURNAL OF HEART FAILURE
- Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion
- (2017) Lucas N.L. Van Aelst et al. EUROPEAN JOURNAL OF HEART FAILURE
- Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Protects Against Acute Kidney Injury–Mediated Chronic Kidney DiseaseNovelty and Significance
- (2017) Lionel Lattenist et al. HYPERTENSION
- What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications?
- (2017) D J Cuthbertson et al. INTERNATIONAL JOURNAL OF OBESITY
- A causal role for hyperinsulinemia in obesity
- (2017) Nicole M Templeman et al. JOURNAL OF ENDOCRINOLOGY
- Abdominal Obesity Is Associated With an Increased Risk of All-Cause Mortality in Patients With HFpEF
- (2017) Tetsuro Tsujimoto et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Metabolically Healthy Obese and Incident Cardiovascular Disease Events Among 3.5 Million Men and Women
- (2017) Rishi Caleyachetty et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Kidney outcomes three years after bariatric surgery in severely obese adolescents
- (2017) Edward J. Nehus et al. KIDNEY INTERNATIONAL
- The Renin Angiotensin Aldosterone System in Obesity and Hypertension
- (2017) Peminda K. Cabandugama et al. MEDICAL CLINICS OF NORTH AMERICA
- Epidemiology of heart failure with preserved ejection fraction
- (2017) Shannon M. Dunlay et al. Nature Reviews Cardiology
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Health Effects of Overweight and Obesity in 195 Countries over 25 Years
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence of Chronic Kidney Disease in Morbidly Obese Japanese and the Impact of Bariatric Surgery on Disease Progression
- (2017) Kotaro Wakamatsu et al. OBESITY SURGERY
- Bariatric Surgery can Reduce Albuminuria in Patients with Severe Obesity and Normal Kidney Function by Reducing Systemic Inflammation
- (2017) Samel Park et al. OBESITY SURGERY
- Effect of large weight reductions on measured and estimated kidney function
- (2017) Bernt Johan von Scholten et al. BMC Nephrology
- The Role of Endotoxin in the Setting of Cardiorenal Syndrome Type 5
- (2017) Anna Clementi et al. CardioRenal Medicine
- Obesity
- (2017) Pedro González-Muniesa et al. Nature Reviews Disease Primers
- Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men
- (2016) M. H. A. Muskiet et al. DIABETES OBESITY & METABOLISM
- Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
- (2016) Lennart Tonneijck et al. DIABETOLOGIA
- A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
- (2016) Gerasimos Filippatos et al. EUROPEAN HEART JOURNAL
- Severity of obesity and cardiometabolic risk factors in adults: Sex differences and role of physical activity. The HERMEX study
- (2016) Alberto Soriano-Maldonado et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction
- (2016) Kenneth B. Margulies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial
- (2016) Meredith A. Brisco et al. JOURNAL OF CARDIAC FAILURE
- Failure and Fatness
- (2016) Amanda R. Vest et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Bariatric Surgery and Emergency Department Visits and Hospitalizations for Heart Failure Exacerbation
- (2016) Yuichi J. Shimada et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- G Protein–Coupled Receptor-G–Proteinβγ–Subunit Signaling Mediates Renal Dysfunction and Fibrosis in Heart Failure
- (2016) Fadia A. Kamal et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Wytyczne ESC dotyczące diagnostyki i leczenia ostrej i przewlekłej niewydolności serca w 2016 roku
- (2016) Piotr Ponikowski et al. Kardiologia Polska
- Bariatric surgery is associated with improvement in kidney outcomes
- (2016) Alex R. Chang et al. KIDNEY INTERNATIONAL
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renal Function and Remission of Hypertension After Bariatric Surgery: a 5-Year Prospective Cohort Study
- (2016) Karl J. Neff et al. OBESITY SURGERY
- Usefulness of Measuring Both Body Mass Index and Waist Circumference for the Estimation of Visceral Adiposity and Related Cardiometabolic Risk Profile (from the INSPIRE ME IAA Study)
- (2015) Julie-Anne Nazare et al. AMERICAN JOURNAL OF CARDIOLOGY
- Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms
- (2015) J. E. Hall et al. CIRCULATION RESEARCH
- The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment
- (2015) M. Volpe et al. CLINICAL SCIENCE
- Comparison of risk factors for acute worsening renal function in heart failure patients with and without preserved ejection fraction
- (2015) Tamiharu Yamagishi et al. European Journal of Internal Medicine
- Fabry’s disease: an example of cardiorenal syndrome type 5
- (2015) Aashish Sharma et al. HEART FAILURE REVIEWS
- Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis
- (2015) A. Ojima et al. HORMONE AND METABOLIC RESEARCH
- Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
- (2015) George L. Bakris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Diuretic response in acute heart failure—pathophysiology, evaluation and therapy
- (2015) Jozine M. ter Maaten et al. Nature Reviews Cardiology
- Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
- (2015) Guanghong Jia et al. Nature Reviews Endocrinology
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Normal Renal Function after Drastic Weight Reduction in Patients with Obesity-Related Glomerulopathy
- (2015) Assumpta Serra et al. Obesity Facts
- Bariatric surgery in patients with reduced kidney function: an analysis of short-term outcomes
- (2015) Fady Saleh et al. Surgery for Obesity and Related Diseases
- The Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries
- (2015) Laurent Calvier et al. JACC-Heart Failure
- Overnutrition, mTOR signaling, and cardiovascular diseases
- (2014) Guanghong Jia et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome-an analysis from RELAX-AHF
- (2014) Adriaan A. Voors et al. EUROPEAN JOURNAL OF HEART FAILURE
- Features of Cardiac Remodeling, Associated With Blood Pressure and Fibrosis Biomarkers, Are Frequent in Subjects With Abdominal Obesity
- (2014) Romain Eschalier et al. HYPERTENSION
- Bariatric surgery and its impact on cardiovascular disease and mortality: A systematic review and meta-analysis
- (2014) Chun Shing Kwok et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The Relationship of Body Mass and Fat Distribution With Incident Hypertension
- (2014) Alvin Chandra et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Basic science
- (2014) Adam Whaley-Connell et al. Journal of the American Society of Hypertension
- Nitric oxide synthases, S-nitrosylation and cardiovascular health: From molecular mechanisms to therapeutic opportunities (Review)
- (2014) ADRIANA V. TREUER et al. Molecular Medicine Reports
- Spironolactone for Heart Failure with Preserved Ejection Fraction
- (2014) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ectopic visceral fat: A clinical and molecular perspective on the cardiometabolic risk
- (2014) Patrick Mathieu et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
- (2014) Giovanni Musso et al. PLOS MEDICINE
- Trends in the Prevalence of Reduced GFR in the United States: A Comparison of Creatinine- and Cystatin C−Based Estimates
- (2013) Morgan E. Grams et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
- (2013) David Z.I. Cherney et al. CIRCULATION
- Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis
- (2013) K. Damman et al. EUROPEAN HEART JOURNAL
- Pathogenesis of Chronic Cardiorenal Syndrome: Is There a Role for Oxidative Stress?
- (2013) Speranza Rubattu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data
- (2013) R Padwal et al. INTERNATIONAL JOURNAL OF OBESITY
- Risk of Myocardial Infarction and Heart Failure Among Metabolically Healthy But Obese Individuals
- (2013) Bjørn Mørkedal et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of Bariatric Surgery on Quality of Life, Functional Capacity, and Symptoms in Patients with Heart Failure
- (2013) William R. Miranda et al. OBESITY SURGERY
- Obesity and Kidney Disease: Potential Mechanisms
- (2013) Christopher Wickman et al. SEMINARS IN NEPHROLOGY
- Obesity and Heart Failure
- (2013) Giovanni Pergola et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Effect of Weight Loss After Bariatric Surgery on Left Ventricular Mass and Ventricular Repolarization in Normotensive Morbidly Obese Patients
- (2012) Rita Mukerji et al. AMERICAN JOURNAL OF CARDIOLOGY
- New Approaches to Sepsis: Molecular Diagnostics and Biomarkers
- (2012) K. Reinhart et al. CLINICAL MICROBIOLOGY REVIEWS
- Ace inhibitor therapy for heart failure in patients with impaired renal function: a review of the literature
- (2012) Ali A. Valika et al. HEART FAILURE REVIEWS
- Prognostic Importance of Early Worsening Renal Function After Initiation of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Cardiac Dysfunction
- (2011) Jeffrey M. Testani et al. Circulation-Heart Failure
- Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome
- (2011) Paolo C. Colombo et al. HEART FAILURE REVIEWS
- Fatty Kidney, Hypertension, and Chronic Kidney Disease
- (2011) Meredith C. Foster et al. HYPERTENSION
- Diuretic Strategies in Patients with Acute Decompensated Heart Failure
- (2011) G. Michael Felker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative Effectiveness of Weight-Loss Interventions in Clinical Practice
- (2011) Lawrence J. Appel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Changes in the Obesity Phenotype Within Canadian Children and Adults, 1981 to 2007–2009
- (2011) Ian Janssen et al. Obesity
- Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study)
- (2010) Aki Hiuge-Shimizu et al. ANNALS OF MEDICINE
- Computed tomography-based validation of abdominal adiposity measurements from ultrasonography, dual-energy X-ray absorptiometry and anthropometry
- (2010) Anna M. I. Gradmark et al. BRITISH JOURNAL OF NUTRITION
- Visceral Adiposity Index: A reliable indicator of visceral fat function associated with cardiometabolic risk
- (2010) M. C. Amato et al. DIABETES CARE
- Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention
- (2010) D Hofsø et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Proinflammatory cytokines in heart failure: double-edged swords
- (2010) Mona Hedayat et al. HEART FAILURE REVIEWS
- Renal Sinus Fat and Poor Blood Pressure Control in Middle-Aged and Elderly Individuals at Risk for Cardiovascular Events
- (2010) Haroon L. Chughtai et al. HYPERTENSION
- Neprilysin, obesity and the metabolic syndrome
- (2010) K F Standeven et al. INTERNATIONAL JOURNAL OF OBESITY
- The Metabolic Syndrome and Cardiovascular Risk
- (2010) Salvatore Mottillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
- (2010) Faiez Zannad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute heart failure in the intensive care unit: Epidemiology
- (2009) Owais Dar et al. CRITICAL CARE MEDICINE
- Efficacy of Spironolactone Therapy in Patients With True Resistant Hypertension
- (2009) Fabio de Souza et al. HYPERTENSION
- Obesity-Related Cardiorenal Syndrome
- (2009) Ryan Nelson et al. Journal of Clinical Hypertension
- Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart Failure
- (2009) Wilfried Mullens et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Safety and Efficacy of Bariatric Surgery in Morbidly Obese Patients with Severe Systolic Heart Failure
- (2008) Gautam V. Ramani et al. CLINICAL CARDIOLOGY
- Increased muscle sympathetic nerve activity predicts mortality in heart failure patients
- (2008) Antonio C.P. Barretto et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cardiorenal Interactions
- (2008) Anju Nohria et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Sympathetic Activation in Chronic Renal Failure
- (2008) M. P. Schlaich et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started